Hello, everyone, and nice to see you again. Another wintry day here on the Pharmalot corporate campus where, as usual, we are doing our best to hustle the short people off to the school houses. And of course, we armed with a shovel and a cup of stimulation - our flavor today is Gingerbread - as we prepare for the next round of deadlines and meetings. We trust you are doing the same, yes? So here are some tidbits to help you get started. May your day be fruitful...
Roche Returns Diabetes Drug To Ipsen Over Side Effects (Bloomberg News)
Sanofi's Multaq On Latest FDA Safety Probe List (Reuters)
China Arrests 18 People For Making Fake Avastin (Shanghai Daily)
Biogen Profit Falls But Tysabri Sales Were Up (Reuters)
Former Pfizer Chemist Gambles On Biofuel (Biodiesel Magazine)
Valeant Pharma To Buy PharmaSwiss For $480M (Reuters)
Bayer Streamlines Healthcare Operations (PharmaTimes)
NPS Pharma Drug For Bowel Syndrome Meets Study Goals (Bloomberg News)
Smiley pic thx to Green Diva on Flickr